As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno ...

CytomX's Phase I trial of ADC CX-2051 in colorectal cancer will continue based on a decision made by a safety committee ...

Regeneron’s second quarter was marked by robust growth in key products, which the company attributed to the strong commercial ...

Dr. Reid brings 30 years of experience in building biotech companies based on innovative scientific platforms and shaping ...

Strand Therapeutics announced on Thursday that it landed a $153 million Series B funding led by Kinnevik. The company’s ...

In today’s CEO Daily: Diane Brady talks to WM CEO Jim Fish. The big story: Trump wants tariffs on buyers of Russian oil. The markets: Broadly up this morning. Plus: All the news and watercooler ...

Palantir CEO Alex Karp Just Delivered Incredible News for Nvidia Stock Investors By Danny Vena – Aug 6, 2025 at 5:02AM ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.

TOKYO (Reuters) -Seven & i Holdings' planned listing of its North American operations would enable the Japanese convenience store operator to take on additional debt for more aggressive growth ...

Starrs, currently the CEO of sports entertainment company Topgolf International, is taking the reins at Harley as the sector faces cost pressures on imported parts and components due to U.S ...